Actively Recruiting
Evaluating Hydeal Cyst with BCG or MMC Treatments in Non-Muscle Invasive Bladder Cancer Patients
Led by Istituto Oncologico Veneto IRCCS · Updated on 2026-08-04
200
Participants Needed
9
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the use of Hydeal Cyst intravesical instillations alongside intravesical chemotherapy or immunotherapy in patients with non-muscle invasive bladder cancer. The study aims to compare standard treatments with BCG or MMC alone versus these treatments combined with Hydeal Cyst. The goal is to assess safety and effectiveness in managing lower urinary tract symptoms during treatment. Treatment begins within 1 to 2 weeks after randomization, which occurs within 12 to 14 weeks post transurethral resection of bladder tumor TURB. Patients receive BCG once weekly for 6 weeks or MMC once weekly for 8 weeks by bladder instillation. For those in the experimental group, Hydeal Cyst is instilled 48 hours after each BCG or MMC treatment, matching the same frequency and duration 6 or 8 instillations respectively. Participants undergo screening including demographic and medical history collection, urine culture, and quality of life and symptom questionnaires. During treatment, physical examinations and symptom evaluations occur weekly prior to instillation. Questionnaires are completed at weeks 1, 4, 6 or 8 during treatment and at 2 weeks, 6 weeks, and 18 weeks after treatment ends. Follow-up includes cystoscopy, urine culture, and assessments of symptoms and quality of life up to 22 weeks from randomization.
CONDITIONS
Brief Title
A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or Immunotherapy in Non-muscle Invasive Bladder Cancer
Research Team
A
Antonio Amodeo, MD
G
Gian Luca De Salvo, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here